Fluorescein Angiography and ROP
Event Details
Course introduction: This ON DEMAND event of our Previously broadcast eSeminar with Dr Swati Agarwal-Sinha will address the role of Fluorescein Angiography in the screening and treatment of Retinopathy of
Event Details
Course introduction:
This ON DEMAND event of our Previously broadcast eSeminar with Dr Swati Agarwal-Sinha will address the role of Fluorescein Angiography in the screening and treatment of Retinopathy of Prematurity (ROP) and other pediatric retinal diseases. It concludes with an extremely informative Q&A Forum!
Learning Objectives:
At the conclusion of this seminar the participants will be able to:
• Define fluorescein angiography and its technique
• Describe the role of fluorescein angiography in the screening and treatment of retinopathy of prematurity
• Discuss the role of fluorescein angiography in other pediatric retinal diseases.
CE Credits:
This course is valid for 1.0 CE Contact hours.
Required provider statement – mark the correct one or add the one to be used
Natus Medical Incorporated is a Provider approved by the California Board of Registered Nursing, Provider Number 16614, for 1.0 contact hours
more
Time
5 (Monday) 12:00 am - 11 (Sunday) 12:00 pm EDT
Speakers for this event
-
Dr. Swati Agarwal-Sinha
Dr. Swati Agarwal-Sinha
Swati Agarwal-Sinha, MD, graduated from the SMS Medical College in Jaipur, India, where she also completed a residency in ophthalmology. She then completed a clinical fellowship in surgical and medical vitreo-retina at Sankara Nethralaya, Chennai, India. After moving to the United States, Dr. Agarwal completed a retina research fellowship at the University of Florida, followed by a clinical fellowship in pediatric ophthalmology and strabismus at the University of Wisconsin in Madison.
As the Director of retinopathy of prematurity services, she specializes in the screening and treatment of premature infants for retinopathy of prematurity and diagnose and treat other pediatric retinal diseases. Dr. Agarwal-Sinha’s research interests include providing screening and treatment for retinopathy of prematurity, anti-angiogenesis injections, pediatric retinal imaging (ocular coherence tomography, fluorescein angiography), and transitional work in the oxygen-induced retinopathy mice model. She is the principal investigator for the Regeneron VGFTe ROP 1920 study. She has published profusely in peer-reviewed journals and has delivered numerous national and international invited lectures.